CCP
ISO

Corient Capital Partners’s IsoPlexis Corporation Common Stock ISO Stock Holding History

Corient Capital Partners’s Portfolio ISO Stock Details ISO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$25K Hold
11,786
– – ﹤0.01% 666
2022
Q2 		$25K Buy
+11,786
New +$27.4K ﹤0.01% 681

Other funds holding ISO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
YU
Yale University New Haven, Connecticut $2.05M AUM 1.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Corient Capital Partners's ISO Position: Q3 2022 in Review

Corient Capital Partners held its IsoPlexis Corporation Common Stock (ISO) position steady in Q3 2022 at 11,786 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

Corient Capital Partners first reported a position in ISO in Q2 2022 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold ISO as of Q3 2022.

  • Corient Capital Partners held 11,786 shares of IsoPlexis Corporation Common Stock worth $25K as of Q3 2022.
  • Corient Capital Partners left its IsoPlexis Corporation Common Stock share count unchanged in Q3 2022.
  • IsoPlexis Corporation Common Stock made up ﹤0.01% of Corient Capital Partners's portfolio in Q3 2022, its #666 holding.
  • Corient Capital Partners first reported a position in IsoPlexis Corporation Common Stock in Q2 2022 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held IsoPlexis Corporation Common Stock as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.